For example, we identified two protein-altering somatic mutations in the KCNB1 gene which occur significantly more frequently in TCGA ovarian cancer samples compared to normal samples (p-value < 0.0001), suggesting that these mutations may be positively selected for in ovarian cancer. This evidence concerns the gene KCNB1 and ovarian cancer.